A Phase II Study of Pentostatin For the Treatment of High Risk or Refractory Chronic GVHD in Children
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2009
At a glance
- Drugs Pentostatin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 02 Feb 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
- 02 Feb 2009 Astex Pharmaceuticals added as trial association as reported by ClinicalTrials.gov.
- 22 Nov 2005 New trial record.